SCHEMBL7688073

SCHEMBL7688073

CC(C)(O)CC[C@H](C[C@@H](O)[CH]Cc1ccccc1F)C(N)=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 5/20 0.51
CHRM2 P08172 1/20 0.39
CCR5 P51681 1/20 0.39
VNN1 O95497 1/20 0.34
RIPK1 Q13546 2/20 0.33
ALDH1A1 P00352 1/20 0.33
SCN3A Q9NY46 1/20 0.32
SLC6A2 P23975 1/20 0.32
SLC6A3 Q01959 1/20 0.32
SCN9A Q15858 1/20 0.32
SIRT2 Q8IXJ6 1/20 0.32
SIRT1 Q96EB6 1/20 0.32
MAOB P27338 1/20 0.31
PARP15 Q460N3 1/20 0.31
PARP14 Q460N5 1/20 0.31
PARP10 Q53GL7 1/20 0.31
ANO1 Q5XXA6 1/20 0.31
HTT P42858 1/20 0.31
KCNH2 Q12809 1/20 0.30
AKR1C3 P42330 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2676320 0.91 CCR1 (0.43) CCR1CHRM2CCR5VNN1RIPK1
SCHEMBL7686534 0.86 CCR1 (0.41) CCR1CHRM2CCR5ALDH1A1SLC6A2
SCHEMBL7686360 0.84 CCR1 (0.41) CCR1CHRM2CCR5VNN1HTT
SCHEMBL2676078 0.84 CCR1 (0.36) CCR1VNN1ALDH1A1SCN3ASLC6A2
SCHEMBL2675109 0.81 CCR1 (0.38) CCR1VNN1RIPK1ALDH1A1
SCHEMBL7688420 0.80 CCR1 (0.51) CCR1CHRM2CCR5VNN1RIPK1
SCHEMBL27608396 0.80 CCR1 (0.51) CCR1CHRM2CCR5VNN1RIPK1
SCHEMBL2676322 0.80 CCR1 (0.60) CCR1CHRM2CCR5RIPK1ALDH1A1
SCHEMBL4068181 0.79 CCR1 (0.36) CCR1VNN1RIPK1ALDH1A1
SCHEMBL7687929 0.78 CCR1 (0.42) CCR1CHRM2CCR5VNN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6403587-B1 AUTOIMMUNE DISEASES, ACUTE AND CHRONIC INFLAMMATORY CONDITIONS, ALLERGIC CONDITIONS, INFECTION ASSOCIATED WITH INFLAMMATION, VIRAL, TRANSPLANTATION TISSUE REJECTION, ATHEROSCLEROSIS, RESTENOSIS, HIV INFECTIVITY, AND PFIZER INC. 2002-06-11 US disclosed